Polymorphs of pyrrole substituted 2-indolinone protein kinase inhibitors
US7452913B2 · kind B2 · utility
10Cited by
6References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 12, 2004 |
| Grant date | Nov 18, 2008 |
| Priority date | — |
| Expiry date | Jul 13, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to polymorphs of the 3-pyrrole substituted 2-indolinone compound 5-(5-fluoro-2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-pyrrolidin-1-yl-ethyl)-amide.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.